Abstract:BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a syndrome of progressive airflow limitation caused by the abnormal inflammatory reaction of the airway and lung parenchyma. Osteoporosis is one of the major extrapulmonary manifestations of COPD. The, prevalence of osteoporosis in COPD patients in Indian population is unknown.OBJECTIVES: To study the prevalence of osteoporosis in COPD and to define various risk factors associated with reduced bone mineral density (BMD) in COPD.MATERIALS AND METHODS: The study was done in the department of Pulmonary Medicine of a tertiary care hospital. All the diagnosed cases of COPD according to the Global Initiative for Obstructive Lung Disease (GOLD) guidelines were included in this study. The present study was a prospective study in for a period of 1 year. A brief history of the patients was taken, especially regarding duration of illness, number of exacerbations in the past 3 years, smoking in pack years, and history of steroid use (both systemic and inhaled steroids) after which cumulative dose of steroids was calculated. Spirometry was done in all these patients to stage the severity of COPD according to GOLD criteria. DEXA scan of the lumbar spine was done using bone densitometer to determine osteoporosis. A world Health Organization (WHO) criterion for definition of osteoporosis was applied and patients with T-score of > -2.5 standard deviation (SD) were diagnosed to have osteoporosis, -1 SD to -2.5 SD were diagnosed to have osteopenia and < -1 SD as normal. Statistical analysis for association of COPD with osteoporosis was done using chi-square test. Risk factors for osteoporosis were identified by univariate and multivariate logistic regression analysis.RESULTS: A total of 102 COPD patients were included in the study. Among these, 68 patients (66.6%) had osteoporosis and 20 patients (19.6%) had osteopenia. Majority (64.7%) of the patients who had osteoporosis had stage III and stage IV COPD disease. It was observed that as the severity grade of COPD increased, the risk of osteoporosis also increased. The bone mineral density (BMD) showed a significant difference among different stages of COPD. As the severity of the stage of COPD increased, BMD decreased. It was also observed that patients with lower body mass index (BMI) had higher prevalence of osteoporosis (37.3%) as compared to overweight patients. On univariate analysis, it was observed that risk factors for osteoporosis were female sex, higher number of exacerbations, BMI, and severity of COPD. After using multivariate logistic regression analysis, stage IV COPD (odds ratio (OR): 34.48, 95% confidence interval (CI): 1.59-1,000, P < 0.02), number of acute exacerbations >3 (OR: 30.3, 95% CI: 4.74-200, P < 0.01), and steroid cumulative dose >1,000 mg (OR: 7.35, 95% CI: 0.92-58.5, P < 0.04) were observed to be significant risk factors for osteoporosis in COPD patients.CONCLUSIONS: In the present study, the prevalence of osteoporosis was 66.6% and another 19.6% had osteopenia. As the severity of COPD increased, the risk of osteoporosis increased. GOLD stage III and stage IV patient had significantly lower BMD as compared to stage I and stage II of COPD disease. Stage IV COPD disease, use of oral or parenteral glucocorticoids, and repeated number of exacerbations were found to be independent risk factors for osteoporosis in COPD patients. Thus, high clinical suspicion and early diagnosis and treatment is required in the evaluation of osteoporosis in COPD patients so that the quality of life can be improved in these patients.

Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India

Exploring prevalence and risk factors association of osteoporosis among chronic obstructive pulmonary disease patients: a cross-sectional study in western Rajasthan

Bone health in ambulatory male patients with chronic obstructive airway disease - A case control study from India

Relationship between chronic obstructive pulmonary disease and osteoporosis in elderly males

Osteoporosis in Asthma and COPD

EFFECT OF INHALED GLUCOCORTICOIDS ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MALE PATIENTS WITH OSTEOPOROSIS

Periodontal health status among chronic obstructive pulmonary disease with age- and gender-matched controls

Disturbance of the OPG/RANK/RANKL Pathway and Systemic Inflammation in COPD Patients with Emphysema and Osteoporosis

Relationship Between Chronic Obstructive Pulmonary Disease and Osteoporosis: A Scoping Review

Analysis of Prescription Pattern, Treatment, and Clinical Outcome in Chronic Obstructive Pulmonary Disease Patients at Tertiary Care Teaching Hospital

Study of bone metabolism in elderly male patients with chronic obstructive pulmonary disease

Prevalence of metabolic syndrome in chronic obstructive pulmonary disease and its correlation with body mass index, airflow obstruction, dyspnea, and exercise index and C-reactive protein

Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study

Severe chronic obstructive pulmonary disease is associated with reduced oral health conditions

Potential Predictive of Thoracic CT Value and Bone Mineral Density T-Value in COPD Complicated with Osteoporosis

PREVALENCE OF OSTEOPOROSIS AND ITS CORRELATION WITH COMMON SECONDARY RISK FACTORS IN POPULATION FROM RURAL AREAS OF SOUTH INDIA

Changes of bone mineral density and bone metabolic markers in old male patients with stable chronic obstructive pulmonary disease

Utility of anthropometric indicators in predicting osteoporosis in ambulant community dwelling rural postmenopausal women from southern India

The assessment of osteoporosis risk factors in Iranian women compared with Indian women

Features of osteoporosis in male patients with bronchiectasis, a cross-sectional study

The prevalence of osteoporosis and its association with serum testosterone and serum vitamin D in the elderly male population: A cross-sectional study